Seibu Giken (6223) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 Feb, 2026Market valuation and performance
Stock price has trended downward since October 2023, impacted by missed earnings and a slowing Chinese economy.
PBR decreased from 1.23 (Dec 2024) to 1.03 (Dec 2025); PER dropped from 11.0 to 9.6 in the same period.
Earnings declined in 2024 and are projected to decline in 2025, keeping the stock below IPO level.
Trust in profit forecasts remains low due to gaps between forecasts and actual results.
Raising awareness of the company and its growth plans is seen as key to improving stock price.
Capital cost and efficiency
CAPM-based cost of equity is estimated at 7–9%, with some investors expecting 8–10%.
Cost of equity based on earnings yield is about 10%.
ROE was 11.8% in 2024, 11.1% in 2025, and is forecasted to return to 11.8% in 2026.
ROE outperforms the 2024 average for manufacturing companies (8.46%).
Initiatives to enhance corporate value
Focus on maintaining ROE at or above 11% through 2026.
Lowering cost of equity by strengthening IR, enhancing materials, and increasing investor engagement.
Steady implementation of the Medium-Term Management Plan to drive profit growth.
Capital policy aims to balance investment and shareholder returns.
Latest events from Seibu Giken
- Record FY2025 results with robust engineering growth; FY2026 to see higher sales but lower margins.6223
Q4 202513 Feb 2026 - Operating profit rose 11.5% YoY despite a 7.5% sales drop, with strong order backlog.6223
Q3 202510 Nov 2025 - Profits increased on high-margin projects, but net assets and comprehensive income declined.6223
Q2 20258 Aug 2025 - Sales up 15.3% YoY, but profit margins declined due to weak China and higher costs.6223
Q3 202413 Jun 2025 - Sales grew but profits fell on margin pressure; outlook positive on EV battery demand.6223
Q2 202413 Jun 2025 - Profits surged on strong Asian sales, but currency losses weighed on comprehensive income.6223
Q1 20256 Jun 2025 - Sales up 11.6% but profits down; FY2025 sees higher sales, lower profits, steady dividend.6223
Q4 20245 Jun 2025